Monoshot™ HA+PRP

Product Description

Monoshot™ HA+PRP is an innovative kit combining hyaluronic acid (HA) with platelet-rich plasma (PRP) for intra-articular injection therapy. HA delivers mechanical lubrication and anti-inflammatory action by reducing matrix metalloproteinase production, while PRP — prepared using the dedicated Monoshot™ separation device — reaches platelet concentrations above 1,000,000 PLT/µl, the clinically recognised threshold for therapeutic efficacy. Combined, the two components provide a synergistic mechanical and regenerative effect, supporting joint tissue repair. A ready-to-use, single-kit solution for clinics and distributors seeking an advanced orthopedic and regenerative medicine product.

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • Founded:
    2008
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
CMO/CDMO
Licensee
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Medical Devices
Specifications
  • Details
    Package of Monoshot™ HA+PRP contains:- Monoshot™ PRP, 
    - separation device (1 pc)
    - Butterfly needle, 21G (1 pc)
    - Needle, 21G (2 pcs)
    - Needle, 19G (1 pc)
    - Single use syringe, 20 mL (1 pc)
    - Single use syringe (with Luer-lock), 10 mL (1 pc)
    - Monoshot™ HA, 3.8 mL, 2.5% sodium hyaluronate in pre-filled syringe (1 pc)
    The product is meant to be used by medical practitioners only.
  • Selling Points
    Bone & Joint Health; Brand Name; Clinical/Therapeutic Benefits
    - Combined mechanical and biological action in a single injection (lubrication, force absorption, anti-catabolic, anti-inflammatory, and regenerative effects) - Synergistic therapy addressing both the mechanical and biological drivers of osteoarthritis, unlike single-component HA or PRP treatments 
    - High-dose HA: 95mg of sodium hyaluronate, MW 1200–3200 kDa 
    - Ultra-concentrated PRP: platelet concentration above 1,000,000 PLT/µl (the recognised therapeutic threshold), achieved via 9.7x concentration versus peripheral blood 
    - Efficient yield: only 13.5ml of patient blood needed to obtain 1ml of highly concentrated PRP  
    Safety
    - No risk of immune response or disease transmission — HA is of bacterial fermentation origin, PRP is autologous 
    - Simple, reliable preparation and administration

  • Supplied from
    Poland

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • Founded:
    2008
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
CMO/CDMO
Licensee
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Medical Devices

More Products from Biovico Sp. z o.o. (12)

  • Biolevox™ HA

    Product Biolevox™ HA

    The Biolevox™ HA product family is based on hyaluronic acid with carefully selected concentration, viscosity and molecular parameters tailored to specific clinical applications.
    • Biolevox™ HA ONE delivers 120 mg of highly purified HA in a single injection. Its USP is clinically confirmed OA symptom ...
  • Lipotris™

    Product Lipotris™

    Liposomal intra-articular gel composite - new generation viscosupplement which ensures supreme lubrication mechanism. Lipotris™ therapy provides accelerated pain relief with sustainable duration of clinical effect. The TRIAD OF AN IDEAL LUBRICATION provides ultra-low friction ratio between cartilage surfac...
  • Xerthra™ kits

    Product Xerthra™ kits

    Xerthra™ is a family of high-performance separation devices for preparing autologous, blood-derived injectable products. Made from Makrolon® polycarbonate with very low surface energy, Xerthra™ minimizes protein/cell binding to the device surface — unlike tube-based kits — ensuring maximum recovery of plat...
  • Wint™ kit

    Product Wint™ kit

    Wint ™ is a unique, high-performance separation device designed to obtain blood derived product rich in DKK-1 (Dickkopf-1) protein- a natural, endogenous inhibitor or Wnt signaling pathway from patient's own blood. Wint™ separation device, due to presence of the exclusive borosilicate activator trigge...
  • FLAVYA™

    Product FLAVYA™

    Flavya™ products are injectable medical devices containing native hyaluronic acid (HA). Flavya™ complements HA deficiencies in dermis, attracts water molecules, neutralizes free radicals, creates conditions for regeneration processes and production of new collagen and elastin fibres in the skin.
    Two v...
  • DKK DERM™ kit

    Product DKK DERM™ kit

    DKK DERM™ kit is designed to obtain an autologous blood-derived product enriched with the DKK-1 protein (DKK-PRP). The DKK DERM™ separation device features an innovative borosilicate platelet activator that selectively induces platelet activation, leading to the release of hig...
  • Xerthra™ BMAC

    Product Xerthra™ BMAC

    Xerthra™ BMAC is an innovative procedure set for separating and concentrating bone marrow aspirate to obtain a concentrated bone marrow fraction (BMAC), used for local injection to enhance tissue regeneration. Its uniquely designed separation devices deliver BMAC with 5 times more concentrated mesenchymal ...
  • AOORA™ kits

    Product AOORA™ kits

    Three AOORA™ procedure packs designed for isolation and separation of high quality blood derived products. The obtained platelet-rich plasma (PRP) contains minimum 1 milion of platelets in 1 μl of plasma, which has the direct impact on the high amount of growth factors delivered in order to revitalize skin...
  • Flavya™ Post Treatment products

    Product Flavya™ Post Treatment products

    Flavya™ Post-Treatment Products are biocellulose-based medical devices infusedwith hyaluronic acid. Due to their occlusive properties, they form a protective barrieron the skin, which is particularly beneficial after medical esthetic treatments.Additionally, their cooling effect helps soothe irritation and...
  • Supplements

    Product Supplements

    Biolevox™ Complex (90 film-coated capsules) supplements the diet with ingredients found in joint structures thus supports the their functioning.
    Chondrovox™ (60 capsules) formulation contains chondroitin sulfate that occurs naturally in joint cartilage. Chondroitin supplementation sup...
  • Progum™

    Product Progum™

    Progum™ is a hyaluronic acid-based product line supporting regeneration in dental and periodontal care. Progum™ HA is a highly concentrated, non-crosslinked native hyaluronic acid (16 mg HA in a 1 mL pre-filled syringe) with physicochemical parameters optimized to promote soft periodontal tissue regen...
  • Ossylbone™

    Product Ossylbone™

    Ossylbone™ is a fully biocompatible, biodegradable and safe material that mimics the natural bone structure and by that its able to effectively support the regeneration of the bone tissue.The Ossylbone™ as an alloplast material is bone substitute material obtained through laboratory chemical synt...

Biovico Sp. z o.o. resources (4)